NIHR Maudsley BRC Blog

Our latest news & events

Next generation of rapid-acting antidepressants: Can ketamine help prevent suicide?

Naghmeh Nikkheslat is a Senior Research Associate at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) who is working on a project funded by the NIHR Maudsley BRC to investigate the use of ketamine as a medication for depression. In this blog, she talks about her research into depression and the immune system and what we currently know about ketamine as an anti-inflammatory antidepressant in psychiatric emergencies.

By NIHR Maudsley BRC at 10 Jan 2022

Psilocybin, in 10mg or 25mg doses, has no detrimental effects in healthy people

New research from King’s College London, in partnership with COMPASS Pathways and supported by NIHR Maudsley BRC, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.

By NIHR Maudsley BRC at 4 Jan 2022

No convincing scientific evidence that hangover cures work, according to new research

A new systematic review has found only very low-quality evidence that substances claiming to treat or prevent alcohol-induced hangover work.

By NIHR Maudsley BRC at 1 Jan 2022

Vitamin D supplementation does not improve symptoms in people with psychosis, study finds

New research involving 149 participants found no evidence that vitamin D supplementation taken over six months improves mental or physical health symptoms in people with psychosis. Participants did however show high rates of vitamin D deficiency which could have longer term health impacts not captured in the study, according to researchers.

By NIHR Maudsley BRC at 28 Dec 2021

NIHR Maudsley BRC: A Year in Review 2021

This year, we have published stories on topics such as the effect of nature on loneliness, new training for eating disorder services and a blood test to reveal underlying neurodegeneration. See a snapshot of the last 12 months at the NIHR Maudsley BRC.

By NIHR Maudsley BRC at 23 Dec 2021